. Immunotherapies for Parkinson's disease: Progression of Clinical Development. CNS Neurol Disord Drug Targets. 2021 May 26; PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.